{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:02:39Z","timestamp":1790168559068,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Care and Resuscitation"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ccrj.2026.100222","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:16:31Z","timestamp":1790165791000},"page":"100222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Persistent lymphopaenia in critically ill patients with and without sepsis: An Australian and New Zealand point prevalence study"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3942-4324","authenticated-orcid":false,"given":"Derick","family":"Adigbli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Devaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Knowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda","family":"Hardie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Gianacas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balasubramanian","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Finfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ccrj.2026.100222_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ccrj.2026.100222_bib2","doi-asserted-by":"crossref","first-page":"e2013","DOI":"10.1016\/S2214-109X(25)00356-0","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132021: a systematic analysis","volume":"13","author":"Gray","year":"2025","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.ccrj.2026.100222_bib3","series-title":"National sepsis program extension epidemiology report","year":"2025"},{"issue":"1","key":"10.1016\/j.ccrj.2026.100222_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1164\/rccm.201403-0471OC","article-title":"Increased 1-year healthcare use in survivors of severe sepsis","volume":"190","author":"Prescott","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccrj.2026.100222_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/SHK.0000000000000981","article-title":"Evidence for persistent immune suppression in patients who develop chronic critical illness after sepsis","volume":"49","author":"Stortz","year":"2018","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.ccrj.2026.100222_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10238-024-01340-0","article-title":"Clinical impact of transient lymphopenia","volume":"24","author":"Petramala","year":"2024","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.ccrj.2026.100222_bib7","first-page":"1097","article-title":"Early persistent lymphopenia and risk of death in critically ill patients with and without sepsis","volume":"10","author":"Adigbli","year":"2023","journal-title":"Shock"},{"issue":"5","key":"10.1016\/j.ccrj.2026.100222_bib8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/SHK.0000000000000234","article-title":"Persistent lymphopenia after diagnosis of sepsis predicts mortality","volume":"42","author":"Drewry","year":"2014","journal-title":"Shock"},{"issue":"5","key":"10.1016\/j.ccrj.2026.100222_bib9","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98960","article-title":"Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial","volume":"3","author":"Francois","year":"2018","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.ccrj.2026.100222_bib10","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00005373-199312000-00007","article-title":"Lymphocyte subset responses to trauma and sepsis","volume":"35","author":"Cheadle","year":"1993","journal-title":"J Trauma"},{"issue":"1","key":"10.1016\/j.ccrj.2026.100222_bib11","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/cc11157","article-title":"Failure to normalize lymphopenia following trauma is associated with increased mortality, independent of the leukocytosis pattern","volume":"16","author":"Heffernan","year":"2012","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.ccrj.2026.100222_bib12","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s13365-018-0657-x","article-title":"Successful treatment of progressive multifocal leukoencephalopathy with recombinant interleukin-7 and maraviroc in a patient with idiopathic CD4 lymphocytopenia","volume":"24","author":"Harel","year":"2018","journal-title":"J Neurovirol"},{"issue":"12","key":"10.1016\/j.ccrj.2026.100222_bib13","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1093\/infdis\/jiy096","article-title":"Interleukin-7 unveils pathogen-specific T cells by enhancing antigen-recall responses","volume":"217","author":"Terrazzini","year":"2018","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.ccrj.2026.100222_bib14","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/13543784.2022.2102477","article-title":"Immune checkpoint inhibitors for the treatment of sepsis: insights from preclinical and clinical development","volume":"31","author":"Rienzo","year":"2022","journal-title":"Expert Opin Invest Drugs"},{"issue":"3","key":"10.1016\/j.ccrj.2026.100222_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/cc11404","article-title":"A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis","volume":"16","author":"Boomer","year":"2012","journal-title":"Crit Care"},{"issue":"23","key":"10.1016\/j.ccrj.2026.100222_bib16","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.2011.1829","article-title":"Immunosuppression in patients who die of sepsis and multiple organ failure","volume":"306","author":"Boomer","year":"2011","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.ccrj.2026.100222_bib17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.21037\/atm.2017.09.21","article-title":"Defects in innate and adaptive immunity in patients with sepsis and health care associated infection","volume":"5","author":"Ryan","year":"2017","journal-title":"Ann Transl Med"},{"issue":"2","key":"10.1016\/j.ccrj.2026.100222_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001019","article-title":"Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management","volume":"8","author":"Mart\u00e9","year":"2020","journal-title":"J ImmunoTher Cancer"},{"key":"10.1016\/j.ccrj.2026.100222_bib19","series-title":"IC-1 document: minimum standards for intensive care units","first-page":"1","year":"2016"},{"issue":"2","key":"10.1016\/j.ccrj.2026.100222_bib20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inf"},{"key":"10.1016\/j.ccrj.2026.100222_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"6","key":"10.1016\/j.ccrj.2026.100222_bib22","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1378\/chest.100.6.1619","article-title":"The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults","volume":"100","author":"Knaus","year":"1991","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.ccrj.2026.100222_bib23","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"issue":"12","key":"10.1016\/j.ccrj.2026.100222_bib24","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.ccrj.2026.100222_bib25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/SHK.0000000000002156","article-title":"Predictive value of soluble programmed cell death ligand-1 in the progression of septic patients to chronic critical illness in the intensive care unit: a prospective observational clinical study","volume":"60","author":"Zeng","year":"2023","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.ccrj.2026.100222_bib26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s00068-025-02864-0","article-title":"Absolute lymphocyte count trajectory predicts clinical outcome in severely injured patients","volume":"51","author":"Reichardt","year":"2025","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"1","key":"10.1016\/j.ccrj.2026.100222_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s13054-024-05099-4","article-title":"Lymphopenia in sepsis: a narrative review","volume":"28","author":"Wang","year":"2024","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.ccrj.2026.100222_bib28","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/SHK.0000000000000347","article-title":"Severe lymphopenia is associated with elevated plasma Interleukin-15 levels and increased mortality during severe sepsis","volume":"43","author":"Chung","year":"2015","journal-title":"Shock"},{"issue":"2","key":"10.1016\/j.ccrj.2026.100222_bib29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/SHK.0000000000001872","article-title":"Admission lymphopenia predicts infectious complications and mortality in traumatic brain injury victims","volume":"57","author":"Campbell","year":"2022","journal-title":"Shock"},{"issue":"29","key":"10.1016\/j.ccrj.2026.100222_bib30","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016535","article-title":"Nonviral infection-related lymphocytopenia for the prediction of adult sepsis and its persistence indicates a higher mortality","volume":"98","author":"Jiang","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.ccrj.2026.100222_bib31","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.4049\/jimmunol.174.8.5110","article-title":"Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways","volume":"174","author":"Hotchkiss","year":"2005","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.ccrj.2026.100222_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13613-023-01109-w","article-title":"Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial","volume":"13","author":"Daix","year":"2023","journal-title":"Ann Intensive Care"},{"issue":"2","key":"10.1016\/j.ccrj.2026.100222_bib33","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1183\/13993003.01359-2015","article-title":"Treatable traits: toward precision medicine of chronic airway diseases","volume":"47","author":"Agusti","year":"2016","journal-title":"Eur Respir J"},{"issue":"23","key":"10.1016\/j.ccrj.2026.100222_bib34","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.2011.1829","article-title":"Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure","volume":"306","author":"Boomer","year":"2011","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.ccrj.2026.100222_bib35","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1001\/jama.2011.1831","article-title":"Immunosuppression in sepsis","volume":"306","author":"Ward","year":"2011","journal-title":"JAMA"}],"container-title":["Critical Care and Resuscitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S144127722600061X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S144127722600061X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:16:36Z","timestamp":1790165796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S144127722600061X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S144127722600061X"],"URL":"https:\/\/doi.org\/10.1016\/j.ccrj.2026.100222","relation":{},"ISSN":["1441-2772"],"issn-type":[{"value":"1441-2772","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent lymphopaenia in critically ill patients with and without sepsis: An Australian and New Zealand point prevalence study","name":"articletitle","label":"Article Title"},{"value":"Critical Care and Resuscitation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccrj.2026.100222","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of College of Intensive Care Medicine of Australia and New Zealand.","name":"copyright","label":"Copyright"}],"article-number":"100222"}}